




















Developmental Biology 223, 70–76 (2000)
doi:10.1006/dbio.2000.9713, available online at http://www.idealibrary.com onSMA-3 Smad Has Specific and Critical Functions
in DBL-1/SMA-6 TGFb-Related Signaling
Cathy Savage-Dunn,*,† Rafal Tokarz,* Huang Wang,† Stephen Cohen,†
hristina Giannikas,* and Richard W. Padgett†
*Department of Biology, Queens College, and The Graduate School and University Center,
City University of New York, Flushing, New York 11367; and †Waksman Institute,
Department of Molecular Biology and Biochemistry, and Cancer Institute
of New Jersey, Rutgers University, Piscataway, New Jersey 08854
A TGFb signal transduction cascade controls body size and male tail morphogenesis in the nematode Caenorhabditis
elegans. We have analyzed the function of the sma-3 Smad gene, one of three Smad genes that function in this pathway. Null
mutations in sma-3 are at least as severe as null mutations in the ligand and type I receptor genes, dbl-1 and sma-6,
indicating that the other Smads do not function in the absence of SMA-3. Furthermore, null mutations in sma-3 do not cause
efects in egg laying or in regulation of the developmentally arrested dauer larva stage, indicating no overlapping function
ith another C. elegans TGFb signaling pathway. The sma-3 gene is widely expressed at all developmental stages in
ermaphrodites and males. The molecular lesions associated with eight sma-3 alleles of varying severity have been
etermined. The missense mutations cluster in two previously identified regions important for Smad function.
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o
tINTRODUCTION
In the nematode Caenorhabditis elegans, a member of
he transforming growth factor b (TGFb) superfamily,
BL-1, controls body size, aspects of male tail morphogen-
sis, and sensory neuron neurotransmitter expression (Su-
uki et al., 1999; Morita et al., 1999; Lints et al., 1999).
BL-1, a BMP (bone morphogenetic protein) homolog, ini-
iates a TGFb signal transduction cascade comprising the
ype I receptor SMA-6 (Krishna et al., 1999), the type II
eceptor DAF-4 (Estevez et al., 1993), and the Smads
MA-2, SMA-3, and SMA-4 (Savage et al., 1996). Mutants
efective in this pathway, the Sma/Mab pathway, are
50% smaller than wild type, have crumpled male copula-
ory spicules, and have defects in the patterning and neu-
otransmitter expression of male sensory rays. A second
GFb signaling pathway, the Dauer pathway initiated by
the TGFb homolog DAF-7, controls entry into the develop-
mentally arrested dauer larva stage and egg laying (Ren et
l., 1996; Trent et al., 1983). The type II receptor DAF-4 is
equired for both pathways, but other signaling components
70re thought to function specifically in one pathway or the
ther.
Smads are intracellular signaling mediators that func-
ion in TGFb signaling cascades (reviewed in Derynck et
al., 1998; Padgett et al., 1998). Three classes of Smads
with functional and sequence differences are recognized:
receptor-regulated (R-Smads), common (Co-Smads), and
antagonistic (Anti-Smads). R-Smads, which include C.
elegans SMA-2 and SMA-3, Drosophila MAD and Smad2,
and vertebrate Smad1, Smad2, Smad3, and Smad5, are
directly phosphorylated and activated by type I receptor
kinase activity (Macı´as-Silva et al., 1996; Zhang et al.,
1996; Kretzchmar et al., 1997; Das et al., 1999). Upon
activation, R-Smads form hetero-oligomeric complexes
with Co-Smads, which include C. elegans SMA-4, Dro-
sophila MEDEA, and vertebrate Smad4, and translocate
to the nucleus (Lagna et al., 1996; Zhang et al., 1996;
Kretzchmar et al., 1997; Wu et al., 1997). Smad com-
plexes act as transcription factors on regulated target
genes through direct DNA binding and cooperation with
other transcription factors (Chen et al., 1996, 1997; Kim
et al., 1997; Liu et al., 1997).
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71sma-3 Smad Gene Mutational AnalysisSmad proteins are 400–600 amino acids in length and are
characterized by two highly conserved domains of ;150
amino acids, MH1 and MH2, separated by a more divergent
proline-rich linker. The MH1 N-terminal domain has
DNA-binding and regulatory functions (Hata et al., 1997;
Kim et al., 1997; Shi et al., 1998). The MH2 C-terminal
omain is required for homo- and hetero-oligomerization
nd transcriptional activation (Liu et al., 1996; Hata et al.,
997; Shi et al., 1997). The crystal structures of both the
H1 and the MH2 domains have been determined, provid-
ng additional insight into how the Smad proteins achieve
heir functions (Shi et al., 1997, 1998).
We have analyzed the structure and function of the C.
legans sma-3 Smad gene, by determining its null pheno-
ype and characterizing an allelic series. We have charac-
erized the expression pattern of the sma-3 gene to investi-
gate its site of action. Finally, we have determined the
molecular lesions associated with eight sma-3 alleles. Our
results indicate a critical and specific role for sma-3 in
DBL-1/SMA-6 signaling and are consistent with the loca-
tion of previously identified structural regions important
for Smad function.
MATERIALS AND METHODS
Nematode strains. Methods for the culturing and genetic ma-
nipulation of C. elegans were as described (Brenner, 1974). In
addition to sma-3 alleles described, the following mutations and
strains were used in these studies: dbl-1(wk70), sma-2(e502),
sma-3(e491), sma-3(e637), sma-3(e958), sma-4(e729), sma-6(wk7),
unc-32(e189), unc-36(e251), him-8(e1489), him-5(e1490), nDf16/
qC1[dpy-19glp-1], nDf16/dpy-17unc-32.
sma-3 genetic analyses. Five alleles of sma-3, wk20, wk21,
wk24, wk27, and wk28, were isolated in a genetic screen for Small
mutants (C.S.-D. and R.W.P., unpublished data) and identified by
their failure to complement sma-3(e491). To allow the identifica-
tion of potentially lethal mutations in sma-3, a noncomplementa-
tion screen was performed. unc-36(e251) hermaphrodites were
mutagenized with EMS and mated with heterozygous sma-
3(e491)unc-32(e189)/11 males. F1 progeny were screened for
Small non-Uncoordinated animals, indicating a new allele of sma-3
on the mutagenized unc-36 chromosome. One new allele, wk30,
was isolated from 10,000 mutagenized haploid genomes.
Hemizygous sma-3 mutants were constructed for five alleles.
Heterozygous sma-3/1 or sma-3unc-32/11 males were mated
with nDf16/qC1 or nDf16/dpy-17unc-32 hermaphrodites. To de-
ermine the viability of sma-3/Df animals, male progeny were
cored for the proportion of Small animals. For the qC1 strain, 35
mall males were found in 183 males scored. For the dpy-17unc-32
train crossed with sma-3unc-32, 57 Uncoordinated, 92 wild-type,
nd 35 Small males were found. In each case, the number of Small
nimals was somewhat less than expected. As a control, the
iability of unc-36/Df animals was also determined. From unc-
6/1 males crossed with nDf16/qC1 hermaphrodites, 16 Uncoor-
inated males were found in 102 males scored. This result suggests
hat the reduced viability of sma-3/Df animals is not due to
owered dosage of sma-3, but to reduced viability of deficiency
eterozygotes in general. To characterize the male tail phenotype
Copyright © 2000 by Academic Press. All rightf sma-3/Df animals, individual Small males from the cross were
icked and examined by Nomarski microscopy.
Growth curves. Gravid hermaphrodites were washed off plates
ith M9 buffer and collected in an Eppendorf tube. Hermaphro-
ites were destroyed with sodium hypochlorite solution, leaving
ggs that were collected and inoculated onto plates with bacteria.
arvae hatched from these eggs were collected at 12, 24, 48, 72, and
6 h and photographed. The length of individual worms was
easured using SigmaScan software, and the results were graphed
sing SigmaPlot. At least 30 nematodes were measured for each
ime point.
sma-3 molecular analyses. A sma-3<lacZ reporter construct,
W2, was generated by amplifying 2.8 kb of genomic DNA
pstream of the sma-3 ATG initiator codon and cloning into the
acZ vector pPD89.03 (A. Fire, personal communication). This
onstruct was introduced into him-5 nematodes with the cotrans-
ormation marker rol-6 by microinjection (Mello et al., 1992) and
ntegrated by g-irradiation. To sequence sma-3 alleles, the sma-3
ene (3 kb genomic DNA) was amplified by PCR from lysed worms.
he PCR fragments were cloned into pBluescript, and at least two
lones were sequenced for each mutant as described previously
Savage et al., 1996).
RESULTS AND DISCUSSION
sma-3 Is Specifically Required for Body Size
Determination and Male Tail Patterning
Most sma-3 alleles were isolated in genetic screens that
allowed the recovery of only viable mutants. Since TGFb
family ligands often have essential roles in other organisms,
we sought to determine whether more severe or lethal
alleles of sma-3 could be isolated. The characterization of
complete loss-of-function (null) alleles of sma-3 also ad-
dresses the question of whether SMA-3 is a pathway-
restricted or common Smad. We used an unbiased genetic
screen (Materials and Methods) to identify mutations that
fail to complement sma-3(e491). One new sma-3 allele,
wk30, was isolated in this screen. This allele contains a
premature stop codon (see below). sma-3(wk30) shows no
more severe phenotype than other strong sma-3 alleles.
Neither sma-3(wk30) nor any other sma-3 mutants show
any appreciable effects on dauer larva formation or egg-
laying behavior. Specifically, we have never seen dauer
larvae on plates with sufficient food, and animals do not
become noticeably bloated due to retention of eggs (n .
1000 for each allele; data not shown). These results confirm
the identification of sma-3 as a pathway-restricted Smad.
sma-3 Mutant Phenotypic Classes
sma-3 alleles can be grouped into three phenotypic
classes, weak, intermediate, and strong, based on the sever-
ity of the Male-abnormal phenotype. The wild-type C.
elegans male tail contains nine pairs of sensory rays ar-
ranged in a precise spatial array. Each of the nine rays has a
unique identity that we assayed by ray position and shape




















72 Savage-Dunn et al.and position of ray opening, as described previously (Savage
et al., 1996). In TGFb-signaling mutants, defects in specifi-
ation of ray identity lead to particular ray fusions. In strong
ma-3 alleles, rays 4 and 5 are fused 9–22% of the time, rays
and 7 fuse 61–82% of the time, and rays 8 and 9 fuse
1–36% of the time (Table 1). The fused rays show charac-
eristics of ray 4, ray 6, and ray 8, respectively: rays 4 and 8
pening ventrally and ray 6 shaped conically with no
erceivable opening. Occasionally, transformations of ray 7
r ray 9 identity that are not accompanied by ray fusion
ccur (Table 1).
Four of nine sma-3 alleles result in the strong phenotype.
wo alleles show very low penetrance (,10%) of the ray
usion defects and are classified as weak. Three alleles are
lassified as intermediate because they show intermediate
requencies of either ray 6–7 or ray 8–9 fusions. The
henotypes of hemizygous animals (sma-3/Df) are not sig-
ificantly different from the phenotypes of the correspond-
ng homozygotes for most alleles tested (Student’s t test,
. 0.05; data not shown). In contrast, the weak allele,
wk20, gives a more severe phenotype when placed in trans
TABLE 1










him-5(e1490) 0% 0% 0
Weak
sma-3(wk20); him-8 2% 0% 3
sma-3(wk20)/Df 30% 20% 0
sma-3(e958); him-5b 5% 8% N
sma-3(e958)/Df 9% 26% 0
Intermediate
sma-3(e491); him-5b 28% 34% N
sma-3(e491)/Df 38% 54% N
sma-3(wk24); him-5 10% 38% 18
sma-3(wk27); him-5 11% 64% 0
Strong
sma-3(e637); him-5 13% 75% 0
sma-3(e637)/Df 37% 80% 4
sma-3(wk21); him-5 9% 61% 3
sma-3(wk28); him-5 9% 82% N
sma-3(wk30); him-5 22% 69% 0
sma-3(wk30)/Df 32% 50% 0
a In wild-type nematodes, rays 8 and 9 fuse at a frequency of ;5
of the fan. In TGFb-signaling mutants, the same frequency of ray 9-l
haracteristics of ray 8, opening at the ventral surface of the fan. For
e did not.
b From Savage et al. (1996).to a chromosomal deficiency (P 5 0.01; Table 1).
Copyright © 2000 by Academic Press. All rightIn most cases, the phenotypes in sma-3 alleles are con-
sistent with different tissues requiring different threshold
levels of sma-3 activity: body size . ray 7 . ray 9 . ray 5
(Table 1). Differential requirements for sma-3 probably
reflect differential requirements for TGFb signaling in these
tissues, as has been suggested by similar findings in sma-4
and sma-6 mutants (Krishna et al., 1999). Two intermediate
sma-3 alleles, however, give frequencies of ray fusions that
are inconsistent with this interpretation (Table 1). sma-
3(wk27) has defects in rays 5 and 7 of frequency similar to
that of strong alleles (P . 0.05; data not shown), but no
defects in ray 9. sma-3(e491) has only an intermediate
frequency of ray 7 defects, similar to that of wk24 (P 5
0.74), but a significantly higher frequency of ray 5 fusions
than wk24 (P 5 0.01). These two mutants thus act as
though they have different levels of sma-3 function in
different tissues. Possibly, the mutant proteins interact
differently with other tissue-specific factors necessary for
signal transduction. The wk27 mutation is a termination
codon late in the SMA-3 coding region (amino acid 268);
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30% 8% 8% 40
0% 0% 0% 47
30% 2% 0% 60
43% 25% 51




d the fused ray has characteristics of ray 9, extending to the edge
sion is seen, but an additional percentage of rays are fused showing














































73sma-3 Smad Gene Mutational AnalysisDBL-1 Signaling Requires Two R-Smads and One
Co-Smad
It is well documented that TGFb signaling requires two
lasses of Smads: the receptor-regulated R-Smads, which
re phosphorylated by type I receptors, and the Co-Smads,
hich form heteromeric complexes with phosphorylated
-Smads (reviewed in Derynck et al., 1998; Padgett et al.,
998). In the Sma/Mab pathway, another level of complex-
ty is seen in the involvement of two Smads of the R-Smad
lass, sma-2 and sma-3 (Savage et al., 1996). We wondered
whether SMA-2 and SMA-4 could transduce any detectable
signal in vivo in the absence of SMA-3. In this case, sma-3
null mutations would be less severe than null mutations in
dbl-1 and sma-6, the signal and type I receptor genes. In
fact, the male tail phenotype of sma-3 mutants is more
severe than that of dbl-1 or sma-6 mutants, although all
three mutations are known nonsense mutations (Table 2).
To ask this question in another way, we compared the
phenotypes of sma-3 single mutants with that of a Smad
triple-mutant strain (Table 2). Here, there is no significant
difference in severity (P 5 0.82), indicating that mutating
the other two Smads causes no further decrease in signaling.
We have characterized the Small phenotype of sma-3 and
other Small mutants by determining their sizes at different
times after hatching. sma-3 and other TGFb signaling
utants hatch as L1 larvae indistinguishable in size from
ild-type larvae (Fig. 1). This contrasts with sma-1 mutant
1 larvae, which are ;50% smaller than wild type, consis-
ent with the role of sma-1 in embryonic elongation rather
han in TGFb signaling (McKeown et al., 1998). sma-3 and
ther TGFb-signaling mutants show defects in postembry-
onic growth, so that by adulthood these mutants are ;50%
shorter than wild type (Fig. 1 and data not shown). As was
seen in the male tail phenotype, the Small phenotype of
sma-3 is more severe than that of dbl-1 or sma-6. Further-
ore, the phenotype of the Smad triple is indistinguishable
TABLE 2










sma-3(e637); him-5 13% 75%
him-8; dbl-1(wk70)a 29% 49% 4




a From Suzuki et al., 1999.
b From Krishna et al., 1999.rom those of dbl-1 and sma-6. Therefore, in body size
Copyright © 2000 by Academic Press. All rightetermination as in male tail patterning SMA-2 and SMA-4
ail to function in the absence of SMA-3. The simplest
nference from these results is the existence of a SMA-2/
MA-3/SMA-4 heteromeric complex that transduces DBL-
/SMA-6 signals. Such a complex has already been detected
or vertebrate Smad2, Smad3, and Smad4 (Nakao et al.,
997). We suggest that the involvement of either one or two
-Smads in TGFb signaling pathways offers an additional













30% 2% 0% 60
15% ND 68% 100
25% ND 139
11% ND 35
FIG. 1. Growth curves for wild-type and Small mutant strains.
N2, dbl-1(wk70), sma-1(e30), sma-3(wk30), sma-6(wk7), and sma-
4(e729)sma-3(e491)sma-2(e502);him-8(e1489) were measured;
dbl-1, sma-3, and sma-6 alleles are known nonsense mutations
(Fig. 3; Krishna et al., 1999; Suzuki et al., 1999). Time indicates the
number of hours after collection of eggs from gravid hermaphro-
dites. At 12 h, most of the animals have hatched as L1 larvae,
except for sma-1 mutants, which may take longer to hatch. By 96 h,





Ddeviation of the data.














74 Savage-Dunn et al.We have determined the expression pattern of the sma-3
gene using a promoter fusion to the lacZ coding region.
This construct is expressed widely at all developmental
stages (Fig. 2). Expression begins during embryogenesis
(data not shown), continues through all larval stages (Fig.
2B), and is very strong in adult hermaphrodites (Fig. 2A) and
males (Fig. 2C). The type I receptor gene sma-6 is expressed
n intestine, pharynx, and other tissues and overlaps the
ma-3 pattern (Krishna et al., 1999). In contrast, dbl-1
xpression is restricted primarily to neurons in the ventral
erve cord and the male tail (Suzuki et al., 1999).
sma-3 Mutations
The molecular lesions associated with eight sma-3 alleles
ave been determined by DNA sequencing (Fig. 3). One
FIG. 3. Molecular lesions in sma-3 mutant alleles. The amino
acid sequence of SMA-3 is shown with mutations in sma-3 alleles
indicated by arrows. The two conserved domains, MH1 and MH2,
FIG. 2. Expression pattern of a sma-3<lacZ transgene in him-5.are underlined. m
Copyright © 2000 by Academic Press. All righteak allele, e958, contained no mutation in sma-3 coding
egions; potential regulatory regions were not sequenced.
wo of four strong alleles, e637 and wk30, are nonsense
utations, supporting the conclusion that this class repre-
ents the null alleles. Two of three intermediate alleles,
k24 and wk27, are also nonsense mutations, but these
mutations terminate near the C-terminus of the protein.
Smad proteins are characterized by two highly conserved
domains of ;150 amino acids, MH1 and MH2. The major-
ity of reported Smad mutations map to the MH2 domain
(Hata et al., 1998). Four of the sma-3 mutations alter
onserved amino acid residues in these two domains. One
FIG. 4. Mapping sma-3 mutations on Smad4 MH2 domain crystal
structure (Shi et al., 1997). The L3 loop is highlighted in red, and
the positions of the e491 (G348R), wk28 (P360L), and wk21 (C361Y)
dult hermaphrodite. (B) L1 larva. (C) Adult male tail.utations are highlighted in green.




















75sma-3 Smad Gene Mutational Analysisweak allele, wk20, has a missense mutation in a conserved
amino acid in the MH1 domain. This mutation borders one
of the loops of the double-loop region identified as a
potential functional surface important for Smad activity
(Shi et al. 1998). Other reported Smad mutations similarly
ffect this double loop region in MH1 (Hata et al., 1998).
The three strong and intermediate mutations cluster in the
L3 loop of MH2: e491 (G348R), wk28 (P360L), and wk21
(C361Y) each alter conserved amino acid residues in this
loop (Fig. 4). The L3 loop forms an exposed surface that is
thought to mediate interactions between Smads and other
proteins and to determine the specificity of Smad interac-
tions with TGFb receptors (Shi et al., 1997; Lo et al., 1998).
ecause these three sma-3 mutations affect conserved resi-
ues, they are likely to interfere with conserved functions
f the L3 loop, rather than altering the specificity of
nteractions. Furthermore, mutations in the L3 loop do not
ffect homo-oligomerization (Shi et al., 1997). Therefore,
hese SMA-3 mutant proteins are probably deficient in
ther protein–protein interactions necessary to their func-
ion. This conclusion is consistent with our finding that
491 shows tissue-specificity in its severity, indicating that
he mutant protein may have differential interactions with
issue-specific cofactors. Our results thus confirm the sig-
ificance of these Smad structural elements in the context
f a developmental pathway.
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